Suchergebnisse - "Queirolo, Paola"

PubPharm (355)

1

Indications for adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma with clear margins : a Delphi consensus

enthalten in: The British journal of dermatology | 2024

von Moscarella, E. | Di Brizzi, E. | Alpi, P. | +22

2

Combined immunotherapy in melanoma patients with brain metastases : A multicenter international study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Mandalà, M. | Lorigan, P. | Sergi, M. | +26

3

Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma : 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial

enthalten in: Nature communications | 2024

von Ascierto, P. | Casula, M. | Bulgarelli, J. | +34

4

The Role of Nicotinamide as Chemo-Preventive Agent in NMSCs : A Systematic Review and Meta-Analysis

enthalten in: Nutrients | 2023

von Tosti, G. | Pepe, F. | Gnagnarella, P. | +4

5

Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma : Should I Stop or Should I Go?

enthalten in: The oncologist | 2023

von Alfieri, S. | Romanò, R. | Marceglia, S. | +19

6

Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL) : a multicentre, open-label, single-arm, phase 2 study

enthalten in: The Lancet. Oncology | 2023

von Dummer, R. | Queirolo, P. | Gerard Duhard, P. | +12

RepublishedFrom: Lancet Oncol. 2022 Sep;23(9):1145-1155. - PMID 35940183

7

Outcomes in patients with BRAFV600-mutated melanoma and brain metastases at baseline treated with dabrafenib plus trametinib

enthalten in: Tumori | 2023

von Aglietta, M. | Chiarion-Sileni, V. | Fava, P. | +17

8

Long-term strategies for management of advanced basal cell carcinoma with hedgehog inhibitors

enthalten in: Critical reviews in oncology/hematology | 2023

von Bossi, P. | Ascierto, P. | Basset-Seguin, N. | +14

9

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma : 5-Year Efficacy and Biomarker Results from CheckMate 238

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Larkin, J. | Del Vecchio, M. | Mandalá, M. | +28

CommentIn: Clin Cancer Res. 2023 Sep 1;29(17):3253-3255. - PMID 37378689

10

Italian nivolumab Expanded Access Programme in melanoma adjuvant setting : patient outcomes and safety profile

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Ascierto, P. | Di Giacomo, A. | Chiarion Sileni, V. | +22

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[36]